Insider · CIK 0001114913

LAPALME PIERRE

Reports to the SEC for 3 companies · NOVATO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001114913

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-03-04	Insys Therapeutics, Inc.A Award	Director	AAward	+8,083 sh	—	—	18,083
2019-03-04	Insys Therapeutics, Inc.A Award	Director	AAward	+8,083 sh	—	—	18,083
2019-03-04	Insys Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director	AAward	+20.9K sh	—	—	20,935
2019-03-04	Insys Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director	AAward	+20.9K sh	—	—	20,935
2018-03-05	Insys Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2018-03-05	Insys Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2018-03-05	Insys Therapeutics, Inc.A Award	Director	AAward	+4,000 sh	—	—	10,000
2018-03-05	Insys Therapeutics, Inc.A Award	Director	AAward	+4,000 sh	—	—	10,000
2018-02-21	Insys Therapeutics, Inc.A Award	Director	AAward	+4,000 sh	—	—	6,000
2018-02-21	Insys Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−4,000 sh	—	—	0
2017-02-21	Insys Therapeutics, Inc.Restricted Stock UnitsA Award	Director	AAward	+4,000 sh	—	—	4,000
2017-02-21	Insys Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2016-05-02	Insys Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2015-06-10	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+1,100 sh	—	—	31,250
2015-06-10	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)A Award	Director	AAward	+3,300 sh	—	—	3,300
2015-05-05	Insys Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2015-03-03	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy Common Stock)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	12,500
2015-03-03	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$11.15	+$112K	40,150
2015-03-03	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$17.33	+$173K	50,150
2015-03-03	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	Director	SSale	−20K sh	$106.57	−$2.13M	30,150
2015-03-03	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy Common Stock)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2014-08-07	Insys Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2013-05-24	Insys Therapeutics, Inc.P Purchase	Director	PPurchase	+2,000 sh	$10.39	+$20.8K	2,000
2013-05-24	Insys Therapeutics, Inc.P Purchase	Director	PPurchase	+1,000 sh	$10.39	+$10.4K	1,000
2013-05-15	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+3,400 sh	—	—	28,050
2013-05-15	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)A Award	Director	AAward	+8,500 sh	—	—	8,500
2013-05-14	Insys Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2013-02-26	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	101,000
2013-02-26	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	Director	SSale	−29.9K sh	$55.34	−$1.65M	24,650
2013-02-26	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,900 sh	—	—	121,000
2013-02-26	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	Director	MExercise/Conversion	+9,900 sh	$8.47	+$83.9K	34,550
2013-02-26	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$11.15	+$223K	54,550
2012-05-08	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+3,400 sh	—	—	24,650
2012-05-08	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)A Award	Director	AAward	+8,500 sh	—	—	130,900
2012-02-28	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	122,400
2012-02-28	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$8.47	+$169K	41,250
2012-02-28	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	Director	SSale	−20K sh	$36.01	−$720K	21,250
2011-05-12	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+2,500 sh	—	—	21,250
2011-05-12	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	142,500
2011-02-24	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	127,400
2011-02-24	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	Director	SSale	−15K sh	$24.94	−$374K	18,750
2011-02-24	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$5.92	+$88.8K	33,750
2011-02-23	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	Director	MExercise/Conversion	+100 sh	$8.47	+$847	18,850
2011-02-23	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−100 sh	—	—	142,400
2011-02-23	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	Director	SSale	−100 sh	$26.00	−$2,600	18,750
2010-05-12	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	142,500
2010-05-12	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+2,500 sh	—	—	18,750
2009-05-22	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+2,500 sh	—	—	16,250
2009-05-22	BMRNBIOMARIN PHARMACEUTICAL INC · Restricted Stock UnitA Award	Director	AAward	−2,500 sh	—	—	0
2009-05-12	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	127,500

Recent filings

Accepted (ET)
Apr 234
LAPALME PIERRE0001209191-19-025626
SEC(opens sec.gov)
Apr 194
LAPALME PIERRE0001209191-19-025410
SEC(opens sec.gov)
May 104
LAPALME PIERRE0001209191-18-029186
SEC(opens sec.gov)
Feb 234
Insys Therapeutics, Inc.0001209191-17-014098
SEC(opens sec.gov)
May 44
Insys Therapeutics, Inc.0001209191-16-117587
SEC(opens sec.gov)
Jun 184
BIOMARIN PHARMACEUTICAL INC0001140361-15-024793
SEC(opens sec.gov)
May 74
Insys Therapeutics, Inc.0001209191-15-039956
SEC(opens sec.gov)
Mar 54
BIOMARIN PHARMACEUTICAL INC0001140361-15-010559
SEC(opens sec.gov)

Companies

Address

C/O BIOMARIN PHARMACEUTICAL INC. 105 DITIAL DRIVE

NOVATO, CA, 94949